Maternity and Neonatal Voices Partnership (MNVP) service

Open

Buyers

Value

£225,000

Classifications

  • Miscellaneous health services

Tags

  • tender

Submission Deadline

1 month from now

Published

20 hours ago

Description

NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board (BNSSG ICB) seeks to commission a Maternity and Neonatal Voices Partnership (MNVP) service for the BNSSG Local Maternity and Neonatal System (LMNS). The MNVP will act as an independent service user-led partnership, working alongside maternity and neonatal providers to gather, analyse and present the experiences of women, birthing people, babies and families, and support continuous quality improvement and co-production.
The service will involve structured engagement, outreach, data collection and analysis, representation at LMNS governance meetings, and collaboration with maternity and neonatal clinical teams across the two acute Trusts within BNSSG. The service will deliver against national MNVP guidance and required outcomes set out by NHS England.
The appointed Provider will employ a small core MNVP team (Trust Lead, Neonatal Lead and Engagement role) and provide the infrastructure, governance, supervision, digital systems and support required to deliver a robust and representative MNVP service.
Key components of the service include:
•	Engagement activity across Bristol, North Somerset and South Gloucestershire.
•	Culturally safe, trauma-informed and inclusive approaches tailored to diverse communities.
•	Strong representation of Black, Asian and minoritised voices, deprived communities, and seldom-heard groups.
•	Collection, analysis and thematic reporting of qualitative and quantitative feedback.
•	Co-production of improvement activities with families and system partners.
•	Active attendance at LMNS governance, safety and quality forums.
•	Support for MNVP volunteers.
•	Social media and communications activity to promote engagement.
•	Applicants should demonstrate how they will support workforce wellbeing and contribute to wider system social value obligations, in line with NHS England requirements. 
•	The Provider will be required to deliver a mobilisation plan including key milestones, risks and mitigations.
The MNVP Strategic and Commissioning Lead will remain employed by BNSSG ICB and will work closely with the commissioned provider.
Due to the changes in the NHS landscape, BNSSG ICB reserves the right to include NHS Gloucestershire Integrated Care Board to join the successful supplier contract during the duration of the contract if it is appropriate to so.  
BNSSG ICB reserves the right under Regulation 41(6) to directly award a subsequent contract under Schedule 5 section 8 (a).
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline active

Publish
Bid
Evaluate
Award
Complete